Latest News and Press Releases

May 12, 2025 Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP...

WARSAW, Poland, May 06, 2025 (GLOBE NEWSWIRE) -- “Thirty years ago, people travelled by rail because they had to. Today, they travel by rail because they want to. In order for people to consider...

Communiqué de presse Eviden coordonne le projet CYDERCO pour le Centre européen de compétences en cybersécurité (ECCC) Un projet de 3 ans cofinancé par la Commission européenne pour renforcer...

Press Release Eviden manages coordination of CYDERCO project funded by the European Cybersecurity Competence Center (ECCC) 3-year project co-funded by the European Commission aims to strengthen...

Der aktualisierte COVID-19-Impfstoff ist auf die Omikron JN.1-Sublinie von SARS-CoV-2 zugeschnitten und wird für Personen ab 6 Monaten empfohlenDie Beurteilung basiert auf präklinischen und...

The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and olderRecommendation is based on pre-clinical and...

Der aktualisierte COVID-19-Impfstoff ist auf die Omikron XBB.1.5-Sublinie von SARS-CoV-2 zugeschnitten und wird für Personen ab 6 Monaten empfohlenDie Beurteilung basiert auf präklinischen Daten, die...

The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and olderRecommendation is based on pre-clinical data...

GAINESVILLE, Va., Sept. 27, 2022 (GLOBE NEWSWIRE) -- The Standard Performance Evaluation Corp. (SPEC) announced the formation of the International Standards Group (ISG) to collaborate with...

Helsinn announces European Commission approval of the liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) Lugano, Switzerland, December 2, 2021 – Helsinn Group, a fully integrated, global...